Daniel Cook MD DHt
1.The U.S. Food and Drug Administration called an Inquiry Meeting about Homeopathic Medicine in the U.S. on April 20-21. The meeting was titled Homeopathic Product Regulation: Evaluating the Food and Drug Administration’s Regulatory Framework after a Quarter-Century. Over the two days a series of presentations were given by the AIH, NCH, HPCUS and other homeopathic organizations and physicians. The hearing was well attended with 9 FDA staff members on the panel to hear the presentations and standing room only for the audience of over 200. The consensus of attendees and those who watched via live video feed was that the FDA panel was respectful, interested to understand the differences and similarities between homeopathic and allopathic products, and attentive to suggestions on any needed changes in regulation. Public comments were also submitted in written form by many organizations in the U.S. Input from the LMHI pharmacy committee was rapidly gathered by Dr. Amarilys Cesar and was very helpful in formulating information prior to the meeting. No official comment or outcome of the meeting has been published by the FDA as this was simply an Inquiry for the FDA to gather information from the community to help in their responsibility for regulating homeopathic medicines in the U.S.
2.The American Institute of Homeopathy has elected a new president, Dr. Ronald Whitmont. Dr. Whitmont has been a long time member of the AIH, is practicing in New York , and is a member of the faculty of the New York Medical College. He succeeds Dr. Irene Sebastian.
3.The AIH is hosting a year-long intermittent seminar with Drs. Praful and Ambrish Vijayakar from Mumbai, India. The seminar is in Newark, NJ and open to any licensed healthcare providers.
4.The U.S. Federal Trade Commission (FTC) is hosting a workshop on September 21, 2015 to evaluate advertising for over-the-counter homeopathic products. The workshop will bring together a variety of stakeholders, including medical professionals, industry representatives, consumer advocates, and government regulators.